W2ST34 fundamentals
An in-depth look to WEST PHARMA DRN operating, investing, and financing activities
W2ST34 free cash flow for Q3 24 is 537.71 M BRL. For 2023, W2ST34 free cash flow was 2.07 B BRL and operating cash flow was 3.88 B BRL.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BRL
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM